Phreesia, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023
September 06, 2023 at 04:03 pm EDT
Share
Phreesia, Inc. reported earnings results for the second quarter and six months ended July 31, 2023. For the second quarter, the company reported sales was USD 22.9 million compared to USD 17.22 million a year ago. Revenue was USD 85.83 million compared to USD 67.87 million a year ago. Net loss was USD 36.77 million compared to USD 46.72 million a year ago. Basic loss per share from continuing operations was USD 0.68 compared to USD 0.89 a year ago.
For the six months, sales was USD 44.6 million compared to USD 32.09 million a year ago. Revenue was USD 169.68 million compared to USD 131.22 million a year ago. Net loss was USD 74.3 million compared to USD 97.96 million a year ago. Basic loss per share from continuing operations was USD 1.39 compared to USD 1.88 a year ago.
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
PHREESIA, INC. 
